Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEB071 pharmacokinetics in de novo liver transplant patients
2007-001361-15Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sotrastaurin in liver transplant, sponsored by Novartis. Primary endpoints: Pharmacokinetics of AEB071 and AEE800 and Safety and tolerability of AEB071. Started Nov 2007; status: completed.
02
Drugs
sotrastaurin
03
Conditions
liver transplant
Beyond the preview
Go deeper on 2007-001361-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001361-15.